Exhibit 23.2
CONSENT OF INDEPENDENT AUDITORS
We consent to the incorporation by reference in the Registration Statement (FormS-3) of CRISPR Therapeutics AG and in the related Prospectus for the registration of common shares, debt securities, warrants, units and subscription rights of our report dated March 8, 2018, with respect to the consolidated financial statements of Casebia Therapeutics LLP, included in the Annual Report (Form10-K) of CRISPR Therapeutics AG for the year ended December 31, 2017.
/s/ Ernst & Young LLP
Boston, Massachusetts
September 19, 2018